双相情感障碍(BD)治疗期间的体重增加——事实与治疗选择
Weight Gain During Treatment of Bipolar Disorder (BD)-Facts and Therapeutic Options.
作者信息
Mangge Harald, Bengesser Susanne, Dalkner Nina, Birner Armin, Fellendorf Frederike, Platzer Martina, Queissner Robert, Pilz Rene, Maget Alexander, Reininghaus Bernd, Hamm Carlo, Bauer Konstantin, Rieger Alexandra, Zelzer Sieglinde, Fuchs Dietmar, Reininghaus Eva
机构信息
Clinical Institute of Medical and Chemical Laboratory Diagnosis, Medical University of Graz, Graz, Austria.
Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria.
出版信息
Front Nutr. 2019 Jun 11;6:76. doi: 10.3389/fnut.2019.00076. eCollection 2019.
Bipolar disorder (BPD) is a mood disorder, which is characterized by alternating affective states, namely (hypo)mania, depression, and euthymia. Evidence is growing that BPD has indeed a biologic substrate characterized by chronic inflammation, oxidative stress, and disturbed energy metabolism. Apart from this, there is obviously a hereditary component of this disease with multi-genetic factors. Most probably a susceptibility threshold favors the outbreak of clinical disease after a cascade of stress events that remain to be elucidated in more detail. Evidence is also growing that weak points in brain energy metabolism contribute to outbreak and severity of BPD. Conventional psychopharmacologic therapy must be reassessed under the aspects of weight cycling and development of central obesity as a deterioration factor for a worse clinical course leading to early cardiovascular events in BPD subgroups.
双相情感障碍(BPD)是一种情绪障碍,其特征是情感状态交替出现,即(轻)躁狂、抑郁和心境正常。越来越多的证据表明,BPD确实具有以慢性炎症、氧化应激和能量代谢紊乱为特征的生物学基础。除此之外,这种疾病显然存在多基因因素的遗传成分。很可能在一系列应激事件之后,一个易感性阈值有利于临床疾病的爆发,而这些应激事件仍有待更详细地阐明。越来越多的证据还表明,脑能量代谢的弱点会导致BPD的爆发和严重程度。在体重循环和中心性肥胖发展方面,传统的心理药物治疗必须重新评估,因为这是导致BPD亚组临床病程恶化并引发早期心血管事件的一个恶化因素。
相似文献
Front Nutr. 2019-6-11
Compr Psychiatry. 2011-5-31
Aust N Z J Psychiatry. 2012-4-17
Int J Bipolar Disord. 2017-9-25
Acta Psychiatr Scand. 2013-2-4
J Affect Disord. 2015-1-15
Acta Psychiatr Scand. 2018-6-3
引用本文的文献
Diabetol Metab Syndr. 2025-1-19
Cochrane Database Syst Rev. 2024-6-4
Nutrients. 2023-11-11
Pharmaceuticals (Basel). 2023-1-30
Front Psychiatry. 2022-7-6
Curr Neuropharmacol. 2023
本文引用的文献
Clin Chem Lab Med. 2019-8-27
J Affect Disord. 2018-12-28
Psychoneuroendocrinology. 2018-11-10
Neuropsychobiology. 2018-9-17
World J Biol Psychiatry. 2018-9-20
World J Biol Psychiatry. 2018-7-27